Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19

J Med Microbiol. 2021 Aug;70(8):001406. doi: 10.1099/jmm.0.001406.

Abstract

Following prolonged hospitalization that included broad-spectrum antibiotic exposure, a strain of Providencia rettgeri was cultured from the blood of a patient undergoing extracorporeal membrane oxygenation treatment for hypoxic respiratory failure due to COVID-19. The strain was resistant to all antimicrobials tested including the novel siderophore cephalosporin, cefiderocol. Whole genome sequencing detected ten antimicrobial resistance genes, including the metallo-β-lactamase bla NDM-1, the extended-spectrum β-lactamase bla PER-1, and the rare 16S methyltransferase rmtB2.

Keywords: COVID-19; NDM carbapenemase; Providencia rettgeri; cefiderocol resistance.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • COVID-19 / complications
  • COVID-19 / therapy*
  • Drug Resistance, Bacterial*
  • Enterobacteriaceae Infections / blood
  • Enterobacteriaceae Infections / etiology
  • Enterobacteriaceae Infections / microbiology
  • Enterobacteriaceae Infections / mortality*
  • Extracorporeal Membrane Oxygenation
  • Fatal Outcome
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Pneumonia, Ventilator-Associated / etiology
  • Pneumonia, Ventilator-Associated / microbiology
  • Pneumonia, Ventilator-Associated / mortality*
  • Providencia / drug effects*
  • Providencia / genetics
  • Providencia / isolation & purification

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Providencia rettgeri